IFP Advisors’s Benitec Biopharma BNTC Stock Holding History

IFP Advisors’s Portfolio BNTC Stock Details BNTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1	Closed	-$11	–	5149
2026 Q1	$11	Hold	1	–	–	﹤0.01%	4958
2025 Q4	$13	Hold	1	–	–	﹤0.01%	4828
2025 Q3	$14	Buy	+1	New	+$13	﹤0.01%	4772

Other funds holding BNTC

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return

IFP Advisors's BNTC Position: Q2 2026 in Review

IFP Advisors sold out of Benitec Biopharma (BNTC) in Q2 2026, closing a stake of 1 share — an estimated $11 sold.

IFP Advisors first reported a position in BNTC in Q3 2025 and held it in 3 quarters. The position peaked at $14 in Q3 2025. 7 funds tracked by Wall St. Rank hold BNTC as of Q2 2026.

IFP Advisors reported no remaining Benitec Biopharma position as of Q2 2026 after selling out during the quarter.
IFP Advisors sold 1 Benitec Biopharma share in Q2 2026, an estimated $11.
IFP Advisors first reported a position in Benitec Biopharma in Q3 2025 and held it in 3 quarters.
IFP Advisors's Benitec Biopharma position peaked at $14 in Q3 2025.
7 funds tracked by Wall St. Rank held Benitec Biopharma as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.